Multiple endocrine neoplasia type 2A. Report of a case with an aggressive outcome;Neoplasia endocrina múltiple tipo 2A. Presentación de un caso de evolución inhabitualmente agresiva

Revista Medica de Chile

Volumn 124, Issue 9, 1996, Pages 1100-1106

  Campusano M, Claudia ^a   Cárdenas G, Isabel E ^b   Olea S, Enrique ^b   Bertin C, Pablo ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b NONE

Author keywords

Drug therapy; Endocrine diseases; Neoplasms; Pheochromocytoma; Prognosis; Thyroid neoplasms

Indexed keywords

ADRENAL TUMOR; ADULT; ARTICLE; BONE TUMOR; CASE REPORT; FEMALE; HUMAN; LIVER TUMOR; MEDULLARY CARCINOMA; METASTASIS; PHEOCHROMOCYTOMA; SIPPLE SYNDROME; THYROID TUMOR;

ADRENAL GLAND NEOPLASMS; ADULT; BONE NEOPLASMS; CARCINOMA, MEDULLARY; FEMALE; HUMANS; LIVER NEOPLASMS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PHEOCHROMOCYTOMA; THYROID NEOPLASMS;

EID: 0030224644     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. RAUE F, FRANK-RAUE K, GRAUER A. Multiple endocrine neoplasia type 2. Endocrinol Metabolism Clin North Am 1994; 23: 137-56.
2. MULLIGAN JM, PONDER BA. Genetic basis of endocrine disease: multiple endocrine neoplasia type 2. J Clin Endocrinol Metabolism 1995; 80: 1989-95.
3. GRAUER A, RAUE F, GAGEL R. Changing concepts in the management of hereditary and sporadic medullary thyroid carcinoma. Endocrinol Metabolism Clin North Am 1990; 19; 613-35.
4. NELKIN B, BALL D, BAYLIN S. Molecular abnormalities in tumors associated with multiple endocrine neoplasia type 2. Endocrinol Metabolism Clin North Am 1994; 23: 187-213.
5. GAGEL R, ROBINSON M, DONOVAN D, ALFORD R. Medullary thyroid carcinoma: Recent progress. J Clin Endocrinol Metabolism 1993; 76: 809-14.
6. SNOW K, BADY A. Management of individual tumor syndromes. Endocrinol Metabolism Clin North Am 1994; 23: 157-66.
7. GOODFELLOW P. Mapping the inherited defects associated with multiple endocrine neoplasia type 2A, multiple endocrine neoplasia type 2B, and familial medullary thyroid carcinoma to chromosome 10 by linkage analysis. Endocrinol Metabolism Clin North Am 1994; 23: 177-85.
8. Wells S, Donis-Keller H. Current perspectives on the diagnosis and management of patients with multiple endocrine neoplasia type 2 syndromes. Endocrinol Metabolism Clin North Am 1994; 23: 215-28.
9. KALLINOWSKI F, BUHR HJ, MEYBIER H ET AL. Medullary carcinoma of the thyroid-therapeutic strategy derived from fifteen years of experience. Surgery 1992; 114: 491-96.
10. SESSIONS R, DAVIDSON BJ. Thyroid cancer. Med Clin North Am. 1993; 77: 517-38.
11. BUSTOS A, BAYLIN S. Medullary carcinoma of the thyroid. En: Werner and Ingebar's The Thyroid. Philadelphia. Library of Congress Cataloging in Publication Data. 1991: 1166-83.
12. DUNN JM, FRANDON JR. Medullary Thyroid carcinoma. Br J Surg 1993; 80: 6-9.
13. BERNA L, CABEZAS R, MORA J ET AL. 11 In-Ocreotide and 99m Tc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma. J Endocrinol 1995; 144: 339-45.
14. OHTA H, YAMAMOTO, ENDO K ET AL. A new imaging agent for medulary carcinoma of the thyroid. J Nucl Med 1984; 25: 323-25.
15. HOEFNAGEL CA. Diagnostic scintigraphy using 1311 metaiodobenzylguanidine for the detection of pheochromocytoma. In: The clinical use of 1311-metaiodobenzylguanidine (MIBG) for the diagnosis and treatment of neural crest tumors. 1990: 39-51.
16. TRONCONE L, RUFINI V, MONTEMAGGI P. The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience. Eur J Nucl Med 1990; 16: 325-35.
17. EVANS D, LEE JE, MARRELL RC ET AL. Adrenal medullary disease in multiple endocrine neoplasia type 2. Endocrinol Metabolism Clin North Am 1994; 23: 167-76.
18. Endocrine Reviews 1994; 15: 356-68.
19. MALLETTE LE. Management of hyperparathyroidism in the multiple endocrine neoplasia syndromes and other familial endocrinopathies. Endocrinol Metabolism Clin North Am 1994; 23: 19-36.